Product NDC: | 54868-4247 |
Proprietary Name: | Terazosin Hydrochloride |
Non Proprietary Name: | Terazosin Hydrochloride |
Active Ingredient(s): | 2 mg/1 & nbsp; Terazosin Hydrochloride |
Administration Route(s): | ORAL |
Dosage Form(s): | CAPSULE |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-4247 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA074823 |
Marketing Category: | ANDA |
Start Marketing Date: | 20000905 |
Package NDC: | 54868-4247-0 |
Package Description: | 30 CAPSULE in 1 BOTTLE (54868-4247-0) |
NDC Code | 54868-4247-0 |
Proprietary Name | Terazosin Hydrochloride |
Package Description | 30 CAPSULE in 1 BOTTLE (54868-4247-0) |
Product NDC | 54868-4247 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Terazosin Hydrochloride |
Dosage Form Name | CAPSULE |
Route Name | ORAL |
Start Marketing Date | 20000905 |
Marketing Category Name | ANDA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | TERAZOSIN HYDROCHLORIDE |
Strength Number | 2 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |